CHS Inc.
NASDAQ:CHSCLAgricultural Farm Products
-$0.05 today
- Market cap
- $294.90M
- Beta
- 0.10
- P/E (TTM)
- 0.0
- EPS (TTM)
- $0.00
- Dividend yield
- 7.37%
Volume 0.12M
Average 0.02M
CHSCL Other Working Capital
Cash effect of changes in other operating assets and liabilities.
CHS Inc.NASDAQ: CHSCL
Other Working Capital · Q2 FY2026 · quarter ended Feb 2026
Other working capital growth accelerates
Q2 FY2026 other working capital of $330.85M rose 46.3% year over year, ahead of the -126.4% change in trailing-twelve-month other working capital.
Context
- Other working capital amounted to 0.4% of revenue in FY2025, up 0.2 pp from a year earlier.
- Other working capital increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +46.3% holds above the trailing-twelve-month pace of -126.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Working Capital history
USD · from the cash flow
- Latest · FY2025
- (142.1M) USD
- Year-over-year change
- -283.0%
| Period | Period end | Other Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-08-31 | (142.1M) | -283.0% |
| FY2024 | 2024-08-31 | 77.64M | +115.5% |
| FY2023 | 2023-08-31 | 36.03M | -42.3% |
| FY2022 | 2022-08-31 | 62.46M | +178.4% |
| FY2021 | 2021-08-31 | (79.7M) | — |
Other Working Capital vs competitors
How CHSCL compares with its peers on the latest reported figures
- Peers report in different currencies, so other working capital is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -126.4% is the 9th highest of 10, against a peer median of -34.8%.
- Other working capital amounts to 0.1% of revenue for CHSCL, versus a peer median of 2.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | R$148.13M BRL | +230.9% | — | 27.1% | |
| LTM Feb 2026 | $32.49M USD | -126.4% | — | 0.1% | |
AFRIForafric Global PLC | LTM Jun 2024 | $21.63M USD | — | — | 6.7% |
| LTM Apr 2026 | $16.76M USD | -41.0% | +20.3% | 0.9% | |
| LTM Mar 2026 | $12.55M USD | +185.2% | — | 2.6% | |
SLSNSolesence, Inc. Common Stock | LTM Mar 2026 | $5M USD | -227.2% | — | 8.3% |
| LTM Mar 2026 | $4.62M USD | -34.8% | -23.8% | 1.1% | |
| LTM Mar 2026 | $4.17M USD | -10.5% | — | 1.8% | |
| LTM Mar 2026 | ₪4.07M ILS | +19.8% | -99.4% | 0.7% | |
| LTM Mar 2026 | $2.27M USD | -69.4% | +7.5% | 13.8% | |
| LTM Apr 2026 | $1.44M USD | -50.0% | — | 1.1% | |
| Peer median (excluding CHSCL) | — | -34.8% | -8.1% | 2.2% | |
Competitors are the stored peer set for CHSCL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Aug 2021 | FY2022 Aug 2022 | FY2023 Aug 2023 | FY2024 Aug 2024 | FY2025 Aug 2025 |
|---|---|---|---|---|---|
| Net Income | 553.95M | 1.68B | 1.9B | 1.1B | 598M |
| Depreciation & Amortization | 461.73M | 461.97M | 464.62M | 481.72M | 651.43M |
| Deferred Income Tax | (11.96M) | 39.55M | (6.43M) | (109.85M) | (38.74M) |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | (190.45M) | (247.58M) | 992.11M | (324.36M) | (464.4M) |
| Accounts Receivables | (568.75M) | (547.56M) | 645.78M | (335.97M) | 7M |
| Inventory | (549.22M) | (317.92M) | 437.69M | 147.76M | (53.18M) |
| Accounts Payables | 1.01B | 555.45M | (127.4M) | (213.79M) | (276.11M) |
| Other Working Capital | (79.7M) | 62.46M | 36.03M | 77.64M | (142.1M) |
| Other Non-Cash Items | (55.47M) | 13.82M | (66.55M) | 123.04M | (110.49M) |
| Operating Cash Flow | 757.81M | 1.95B | 3.28B | 1.27B | 635.79M |
| Capital Expenditures | (358.72M) | (379.21M) | (781.94M) | (831.51M) | (999.96M) |
| Acquisitions (Net) | 102.11M | 87.47M | 29.71M | 15.82M | (237.17M) |
| Purchases of Investments | 0 | 0 | 0 | (500.18M) | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 513.31M |
| Other Investing Activities | 154.94M | (165.34M) | (197.97M) | (947.23M) | (1.16B) |
| Investing Cash Flow | (101.67M) | (457.08M) | (950.19M) | (1.43B) | (880.6M) |
| Debt Repayment | (41.84M) | (785.17M) | (202.42M) | 74.22M | 525.54M |
| Common Stock Issued | 79.38M | 111.82M | 0 | 0 | 0 |
| Common Stock Repurchased | (79.38M) | (111.82M) | (495.79M) | (355.93M) | (287.68M) |
| Dividends Paid | (168.67M) | (168.67M) | (168.67M) | (168.67M) | (469.03M) |
| Other Financing Activities | (36.7M) | (48.03M) | (528.59M) | (363.88M) | 600K |
| Financing Cash Flow | (326.59M) | (1.11B) | (1.4B) | (814.25M) | (230.57M) |
| Effect of Forex Changes | (4.06M) | (14.76M) | 2.59M | 2.24M | 773K |
| Net Change in Cash | 325.49M | 360.99M | 941.11M | (970.73M) | (474.6M) |
| Free Cash Flow | 399.1M | 1.57B | 2.5B | 441.37M | (364.17M) |
CHS Inc.
NASDAQ:CHSCL
Intrinsic Alpha fair value
Locked
Current Price
$24.03
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.